Generate a tailored SOP for Dr. Hans Schreiber. Improve your application with a focused, well-structured draft.
Hans Schreiber is a Professor in the Biological Sciences Division at the University of Chicago, focusing on the interplay between cancer cells and the immune system. His research investigates the fundamental mechanisms governing these interactions, specifically how cancer cells express unique mutations and antigens that can be targeted by the immune response to destroy disseminated cancer cells. By understanding the pathways that allow immunogenic cancer cells to evade immune destruction, Schreiber aims to develop novel therapeutic strategies. His laboratory employs a combination of immunology, genetics, and biochemistry to identify critical immunological targets. Schreiber's extensive educational background includes a Ph.D. from the University of Chicago and postdoctoral training in experimental carcinogenesis. He has published numerous influential papers on T-cell receptor selection and the treatment of cancer, contributing to advancements in immunotherapy for various malignancies.
Department of Philosophy